Staffan Folestad - Articles and news items

PAT in the pharmaceutical industry

Issue 4 2007 / 21 July 2007 / Don Arnone, Teraview / Gawayne Mahboubian-Jones, Optimal Automation / Vinod Mehta, Carl Zeiss / Christian Woelbeling, Werum Software & Systems AG / Denise Root, Foss / Ingrid Maes, Siemens / Chris Hobbs, ABB

European Pharmaceutical Review brings you a comprehensive guide to the current developments and possible future innovations within Process Analytical Technologies.

EuPAT: an initiative to promote progress in the science underpinning PAT

Issue 3 2007 / 23 May 2007 / Staffan Folestad, Senior Principal Scientist, AstraZeneca, Sweden; Peter York, Bradford University, UK, and Rasmus Bro, Copenhagen University, Denmark

A new initiative launch has been announced that aims to promote progress in the science underpinning Process Analytical Technology. The core purpose of the EuPAT meeting is the creation of an open and neutral scientific forum for sharing and discussing new findings in cutting-edge scientific research, development of enabling technologies and development of innovative applications. Building on the successful EuPAT1 conference in Gothenburg, November 2006; the EuPAT2 conference has been announced for November 2007 in Copenhagen.

New opportunities for understanding

Issue 3 2006, Past issues / 23 May 2006 / Lubomir Gradinarsky, Jonas Johansson, Mike Claybourn, Husheng Yang, Matti U.A. Ahlqvist and Staffan Folestad, Pharmaceutical and Analytical R&D, AstraZeneca R&D Mölndal

By taking advantage of new technology previously developed mainly for radio astronomy, biological investigations and military applications, the emerging field of Terahertz (THz) Spectroscopy is starting to make its way into pharmaceutical analysis. This overview describes the new opportunities with THz Spectroscopy for rapid and non-destructive analysis of pharmaceutical materials such as powders and tablets.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...